Early screening for lung nodules with breath, blood, and CT scans
Part of Cancer, Lungs & breathing clinical trials.
This trial uses a new, non-invasive way to screen for lung cancer by combining your breath, blood, and CT scan images. The goal is to figure out whether a nodule found on a CT scan is cancerous or not, which could help patients avoid unnecessary procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- A lung nodule smaller than 3 cm was found on a CT scan and will be surgically removed.
- You have not been treated for any cancer before.
- You have not received chemotherapy, radiation, or targeted therapy.
- Your breath, blood, and CT scan were all collected within a month before surgery, and you didn't start any anti-cancer treatment in that time.
- You must be willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a simple breath test to see if it can tell whether a lung nodule is cancer or not. If you have a lung nodule that will be removed by surgery, you may be able to help find out if breathing into a device can replace more invasive tests.
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
This trial follows people with lung nodules over time, using blood and tissue samples to look for metabolic changes that may help understand lung cancer better. If you have a lung nodule found on a CT scan and can safely do lung function tests, this study may be a fit.
This study tests a breath test to detect lung cancer early in people with a lung nodule found on a CT scan. It aims to improve detection in diverse populations.
This study looks at whether a new test can better identify early lung cancer in people who are being watched for an incidental lung nodule. It may help doctors decide which nodules need closer follow-up or treatment.
This study looks at whether MRI scans and blood-related biomarkers can help better understand lung nodules found during routine lung cancer screening. It may help doctors decide which nodules need closer follow-up versus less intensive monitoring.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.